Search and analyze individual stocks with comprehensive metrics
MAITREYA MEDICARE
Fundamental Score
MAITREYA MEDICARE Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of MAITREYA across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Conservative Debt Levels (D/E: 0.14)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Balanced Promoter Holding (73.11%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
9 factors identified
Below-Average Return on Equity (7.17%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 1049.00x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-102.40%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Weak Interest Coverage (2.28x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-0.26 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Loading Peer Comparison
Finding companies in the Hospital sector...
Financial Statements
Comprehensive financial data for MAITREYA MEDICARE
About MAITREYA
Company Details
MAITREYA Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of MAITREYA MEDICARE (MAITREYA)?
As of 16 Jan 2026, 10:12 am IST, MAITREYA MEDICARE (MAITREYA) is currently trading at ₹214.15. The stock has a market capitalization of ₹167.84 (Cr).
Is MAITREYA share price Overvalued or Undervalued?
MAITREYA is currently trading at a P/E ratio of 1049.00x, compared to the industry average of 52.84x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the MAITREYA MEDICARE share price?
Key factors influencing MAITREYA's price include its quarterly earnings growth (Sales Growth: -2.71%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is MAITREYA MEDICARE a good stock for long-term investment?
MAITREYA MEDICARE shows a 5-year Profit Growth of N/A% and an ROE of 7.17%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.14 before investing.
How does MAITREYA MEDICARE compare with its industry peers?
MAITREYA MEDICARE competes with major peers in the Hospital. Investors should compare MAITREYA's P/E of 1049.00x and ROE of 7.17% against the industry averages to determine its competitive standing.
What is the P/E ratio of MAITREYA and what does it mean?
MAITREYA has a P/E ratio of 1049.00x compared to the industry average of 52.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹1049 for every ₹1 of annual earnings.
How is MAITREYA performing according to Bull Run's analysis?
MAITREYA has a Bull Run fundamental score of 16/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does MAITREYA belong to?
MAITREYA operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting MAITREYA MEDICARE.
What is Return on Equity (ROE) and why is it important for MAITREYA?
MAITREYA has an ROE of 7.17%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently MAITREYA MEDICARE generates profits from shareholders' equity.
How is MAITREYA's debt-to-equity ratio and what does it indicate?
MAITREYA has a debt-to-equity ratio of 0.14, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is MAITREYA's dividend yield and is it a good dividend stock?
MAITREYA offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has MAITREYA grown over the past 5 years?
MAITREYA has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in MAITREYA and why does it matter?
Promoters hold 73.11% of MAITREYA shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is MAITREYA's market capitalization category?
MAITREYA has a market capitalization of ₹168 crores, placing it in the Small-cap category.
How volatile is MAITREYA stock?
MAITREYA has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for MAITREYA?
MAITREYA has a 52-week high of ₹N/A and low of ₹N/A.
What is MAITREYA's operating profit margin trend?
MAITREYA has a 5-year average Operating Profit Margin (OPM) of 12.21%, indicating the company's operational efficiency.
How is MAITREYA's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -2.71% and YoY Profit Growth of -102.40%.
What is the institutional holding pattern in MAITREYA?
MAITREYA has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.